Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Norfolk Southern Corporation (NSC) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Norfolk Southern CorporationTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Norfolk Southern Corporation vs Health Care Select Sector SPDR Fund — how do they compare? Norfolk Southern Corporation trades at $317.43 (market cap $71.20B), while Health Care Select Sector SPDR Fund trades at $170.91 (market cap $43.48B). The key difference: Norfolk Southern Corporation is the larger of the two by market cap, and Norfolk Southern Corporation pays a 1.7% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Norfolk Southern Corporation for 33 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

NSCXLV
Market Cap
$71.20B$43.48B
Volume
555,24811,121,431
Sector
Industrials—
52-Week High
$352.98$175.68
52-Week Low
$278.19$141.95
Typical Hold Time
33 Days100 Days
Enterprise Value
$86.75B—
Dividend Yield
1.7%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Norfolk Southern Corporation

Norfolk Southern (NSC) trades at $317.14, up 1.26% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $361.86. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Strong profitability is evidenced by a 21.02% net income margin and 16.97% ROE, while news highlights significant institutional investment and progress on the proposed merger with Union Pacific.

The outlook is positive, supported by earnings momentum and potential merger benefits, but risks include integration challenges, fuel cost pressures noted in recent news, and a relatively high P/E ratio of 27.05. The stock offers a dividend yield and growth potential, contingent on successful execution of strategic initiatives.

Health Care Select Sector SPDR Fund

XLV trades at $169.58 with a slight 0.46% daily gain amid bearish technical signals. The ETF faces selling pressure with moving averages indicating downward momentum while oscillators remain neutral. Recent news highlights XLV's competitive expense ratio of 0.08% and defensive healthcare sector positioning. Options activity shows increased put volume, suggesting some investor caution despite the fund's diversification across 61 healthcare stocks.

The healthcare ETF presents a cost-effective defensive play with potential upside if political volatility subsides post-elections. Key risks include sector-specific regulatory pressures and biotech trial failures impacting holdings. Current technical weakness near support at $166 requires monitoring for potential breakdown, though the fund's low fees and broad diversification provide stability during market uncertainty.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NSC

No sentiment data available yet.

XLV
53% Buy47% Sell
Avg holding period · 100 Days

About Norfolk Southern Corporation

Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.

Read more on NSC →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →